The Global Metagenomic Sequencing Market Is Driven By Increasing Demand For Microbial Genomics-based Diagnostics

By Author: Ben
Total Articles: 165
Comment this article

The Global Metagenomic Sequencing Market involves sequencing of DNA extracted directly from environmental samples containing complex microbial communities without culturing. It provides a culture-independent assessment of microbial diversity and assists in functional study of microbes in relation to human health and disease. Metagenomic sequencing has advantage of analyzing genetic content of entire microbial communities. It is cost-effective, enables identification of novel genes and metabolic potential of uncultured organisms, and helps rapid generation of genetic sequences without need to isolate or culture individual microbial strains.

The Global Metagenomic Sequencing Market Size is estimated to be valued at US$ 1.41 Bn in 2024 and is expected to exhibit a CAGR of 17% over the forecast period 2024-2031.

Key Takeaways

Key players operating in the Global Metagenomic Sequencing Market are Illumina, QIAGEN, Thermo Fisher Scientific, Oxford Nanopore Technologies, BGI Group, PerkinElmer, GENEWIZ, Macrogen, Zymo Research, Diversigen, Microsynth AG, BaseClear, MR DNA (Molecular Research), Eurofins Scientific, ...
... Novogene Corporation, NuGEN Technologies, Takara Bio, Swift Biosciences, New England Biolabs, and CosmosID.

Growing demand in the market is driven by increasing application of metagenomics in clinical diagnostics for identification of pathogens in clinical samples without need for culture. It is helping diagnose challenging infections and identify novel disease markers.

The Global Metagenomic Sequencing Market is witnessing expansion in various geographies and countries are increasingly investing in building genomic databases to better understand disease spread and epidemiology. Developed regions are dominant however developing regions are witnessing fastest growth supported by increasing research activities and funding.

Market Drivers

The key driver for the Global Metagenomic Sequencing Market is increasing demand for microbiome analysis driven by growing significance of microbiome in human health and disease. Understanding roles of microbiome is crucial for developing effective diagnostics, therapeutics and preventive strategies for many diseases like cancer, obesity, diabetes, neurological and gastrointestinal disorders. Metagenomic sequencing allows comprehensive profiling of microbial communities to gain novel insights. This is expected to further drive its adoption.

Geopolitical Impact on Market Growth

The current geopolitical situation has created significant challenges and uncertainties for the global metagenomic sequencing market. The ongoing geopolitical tensions and armed conflicts in various parts of the world have disrupted supply chains and trade dynamics. This has restricted the movement of goods, people and hampered collaboration between research groups across borders. Many international conferences and scientific exchanges have also been cancelled or postponed. All of these factors have slowed down research activities involving metagenomic sequencing to some extent. For the market to realize its full growth potential in the coming years, stakeholders will need to explore alternate collaboration models that can overcome geopolitical barriers through virtual and digital means wherever possible. Cross-border data sharing policies also need to be strengthened while ensuring privacy and security. Regional alliances focused on metagenomics can complement global collaborations and help offset disruptions due to geopolitical issues to a certain level.

Asia Pacific Represents Largest Region

The Asia Pacific region currently accounts for the largest share of the global metagenomic sequencing market in terms of value. This is due to the presence of populous, high growth economies like China and India which are investing heavily in genomics and biotechnology research. Countries like China, Japan, South Korea and Singapore have emerged as major hubs for metagenomic studies. Favorable government policies boosting R&D expenditures, rising awareness about precision medicine, growing incidence of chronic and infectious diseases are some of the key factors driving the demand for metagenomic sequencing in Asia Pacific. The region's large population also provides researchers with access to diverse datasets needed for metagenomics applications.

Latin America to Witness Fastest Growth

Latin America is poised to witness the fastest growth in the metagenomic sequencing market during the forecast period. This is attributed to ongoing development of research institutes and genome centers, increasing healthcare expenditures, rising collaborations with global pharmaceutical companies in drug development. Countries such as Brazil, Mexico, Argentina are adopting metagenomics for applications ranging from environmental monitoring, agricultural biotechnology to medical diagnostics. Initiatives aimed at improving regional scientific infrastructure and skill development and attracting investments from global players are further strengthening Latin America's position as a high potential market for metagenomic sequencing.

What Are The Key Data Covered In This Global Metagenomic Sequencing Market Report?
:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the Global Metagenomic Sequencing Market’s growth between 2024 and 2031.

:- Accurate calculation of the size of the Global Metagenomic Sequencing Market and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- Global Metagenomic Sequencing Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market’s competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of Global Metagenomic Sequencing Market vendors

FAQ’S

Q.1 What are the main factors influencing the Global Metagenomic Sequencing market?

Q.2 Which companies are the major sources in this industry?

Q.3 What are the market’s opportunities, risks, and general structure?

Q.4 Which of the top Global Metagenomic Sequencing Market companies compare in terms of sales, revenue, and prices?

Q.5 Which businesses serve as the Global Metagenomic Sequencing market’s distributors, traders, and dealers?

Q.6 How are market types and applications and deals, revenue, and value explored?

Q.7 What does a business area’s assessment of agreements, income, and value implicate?

Get more insights on this topic:https://dailygram.com/blog/1296535/global-metagenomic-sequencing-market-will-grow-at-highest-pace-owing-to-ris/